Taiwan's biotech innovation gains global recognition. APN LifeSciences has announced a strategic investment from the Alzheimer’s Drug Discovery Foundation (ADDF). Founded by the family behind global beauty giant Estée Lauder, the ADDF’s backing will accelerate the development of APN 1607.
Read more